Drug Type Gene therapy |
Synonyms Adenoviral-mda7, Mda 7 gene therapy, AD-MDA7 + [1] |
Target |
Action stimulants |
Mechanism IL-24 stimulants(Interleukin 24 stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Head and Neck Neoplasms | Phase 3 | United States | - | |
Head and Neck Neoplasms | Phase 3 | - | - | |
Head and Neck Neoplasms | Phase 3 | - | - | |
Melanoma | Phase 2 | United States | 01 Mar 2005 | |
Advanced cancer | Phase 1 | United States | 01 May 2004 | |
Advanced cancer | Phase 1 | United States | 01 May 2004 | |
Advanced cancer | Phase 1 | United States | 01 May 2004 | |
Breast Cancer | Preclinical | United States | - | |
Breast Cancer | Preclinical | - | - | |
Breast Cancer | Preclinical | - | - |
Phase 1 | 18 | INGN 241 (Ad-mda7) | zjaitkfiyb(negfbnynze) = pain at the injection site, transient low grade fever and mild flu-like symptoms jbssojaqso (rnlqfzgxca ) View more | Positive | 01 May 2003 |